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median (range) ANC and ALC at the time of RSV diagnosis was
1.6 (0 - 11) and 0.8 (0 - 7.3), respectively. Among the 35 pa-
tients with URTI, 12 received IR while 23 did not. None of the
12 patients treatedwith IR progressed to LRTI. In contrast, 6 of
the 23 untreated patients (24%) with URTI progressed to LRTI.
Of the 31 patients with LRTI (25 initially diagnosed with LRTI
and 6 patients who progressed from URTI to LRTI), there were
four deaths occurring within 60 days of RSV diagnosis (two
deaths directly from RSV, one from disease relapse, and one
from GVHD). In patients with LRTI (25 patients with LRTI at
diagnosis plus 6 patients who progressed from URTI to LRTI),
RSV-related mortality was (6.4%). On univariate analysis, only
the presence of GVHD signiﬁcantly predicted the develop-
ment of LRTI in patients with URTI (P ¼ .028); however, the
use of inhaled ribavirin had a protective effect that was
marginally signiﬁcant (P¼ .074). Early use of IR in high-risk
transplant and leukemia patients can both reduce the pro-
gression fromURTI to LRTI and improve the historically dismal
outcomes of patients with RSV pneumonia.297
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Clinical Question (in PICO format)
Background / Purpose of BESt Development
Hemopoietic stem cell transplant can have profound and
lasting adverse effects on an individual’s physical and psy-
chological well-being (Wolin 2010 [1a], Tsimicalis 2005 [1a],
Baumann 2011 [2b], Jarden 2009 [2b]). The HSCT treatment
results in a decline in physical function functioning related to
loss of muscle mass and muscle strength andmuscle atrophy
is associated with several transplant related problems,
including immunosuppressive therapy, bed rest, and drug
toxicities (Wolin 2010 [1a], Knols 2005 [1a], Wiskemann 2008
[1b], Baumann 2011 [2b]). The experience of the isolated
environment and the stress of a life threatening illness,
resulting in fatigue, anxiety, depression, and fear, may also
contribute to negative effects on physical function and QoL
(Tsimicalis 2005 [1a]).
Chemotherapy results in anemia, which can affect cardiore-
spiratory ﬁtness and cause skeletal muscle atrophy and
weakness. Chemotherapy toxicities can impede adequate
nutrition needed to maintain muscle mass. Radiation therapy
can lead to lung ﬁbrosis, resulting in decreased pulmonary
function. Cranial radiation in childhood has been strongly
linked to physical inactivity during adulthood (Wolin 2010
[1a]). Individuals being treated for pediatric cancers, in
particular, tend to experience adverse effects of treatment
including impaired growth, decreased neurological and/or
cardiac function, endocrine complications, osteoporosis and
obesity (Wolin 2010 [1a]). All of these side effects can lead to a
decline in physical functioning and contribute to experiences
of fatigue, anxiety, and depression (Wolin 2010 [1a]).P: Among school aged children and adolescents receiving
hemopoietic stem cell transplant (HSCT)
I: does physical therapy (PT) intervention (active participation
in mobility, endurance, strength exercise)
C: compared to no intervention
O: improve the patient’s quality of life (QoL)?In addition to the symptoms and side effects, the treatment
requires prolonged isolation, which can also impede func-
tional activity and impair psychological well-being (Trem-
olada 2009 [1b]). Activity restrictions and limited exercise
options hinder the individual’s ability to sustain physical
function throughout this process. Mentally, the challenges
pediatric patients experience while undergoing HSCT may
have a long lasting impact on QoL (Tremolada 2009 [1b]).
Because survival rates have increased, the need to address
these quality of life issues and the impact of functional
impairment has grown signiﬁcantly. It is important to
consider not only immediate survival, but also long term
recovery of this patient population. The purpose of devel-
oping this BESt was to identify interventions that can
improve function and positively impact outcomes improving
HSCT pediatric patients’ QoL.298
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Backgrounds: Both tacrolimus and glycopeptide antibiotics
are nephrotoxic, and are frequently co-administered after
hematopoietic stem cell transplantation (HSCT). The aim of
this study is to evaluate the nephrotoxicity of co-adminis-
tration of tacrolimus and glycopeptide antibiotic, teicoplanin,
in HSCT recipients.
Patients and Methods: Sixty-seven patients who received
intravenous tacrolimus and teicoplanin concomitantly for
more than four days after allogeneic HSCT were retrospec-
tively examined. Therapeutic drug monitoring (TDM) was
performed in all patients both for tacrolimus and teicoplanin.
Results: The median duration of the co-administration of
tacrolimus and teicoplanin was 11 days (range: 4-40). The
mean serum creatinine (sCr) level tended to be elevated after
the co-administration of tacrolimus and teicoplanin (from
0.690.26 to 0.750.30 mg/dL; P¼ 0.08); however, a two-
fold or greater increase of sCr was observed only in 2 (3.0%)
patients. Increased sCr was tolerable and reversible.
Conclusion: These results suggest that the nephrotoxicity of
the co-administration of tacrolimus and teicoplanin is min-
imal after allogeneic HSCT if the TDM of each drug is properly
applied.299
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Japanese encephalitis (JE) virus is one of the most wide-
spread causes of viral encephalitis in Asia and western pa-
ciﬁc. JE causes long-term neurological morbidities and
mortality. National implementation of JE vaccine effectively
reduces incidences of JE in Asian countries. A live-attenuated
